Inhibition of chronic graft-vs-host disease with retention of anti-myeloma effects by the proteasome inhibitor bortezomib

Leuk Lymphoma. 2007 May;48(5):1015-8. doi: 10.1080/10428190701253843.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Alanine Transaminase / metabolism
  • Alkaline Phosphatase / metabolism
  • Aspartate Aminotransferases / metabolism
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Chronic Disease / drug therapy
  • Graft vs Host Disease / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Protease Inhibitors / therapeutic use*
  • Proteasome Inhibitors*
  • Pyrazines / therapeutic use*
  • Recurrence
  • Remission Induction
  • gamma-Glutamyltransferase / metabolism

Substances

  • Boronic Acids
  • Protease Inhibitors
  • Proteasome Inhibitors
  • Pyrazines
  • Bortezomib
  • gamma-Glutamyltransferase
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Alkaline Phosphatase